Skip to main content

Table 6 Characteristics of IBD patients treated with or without biologics in 2014 (n = 4812)

From: Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

n (%)

IBD (total)

No Biologics

Biologics

p a

 

n = 4812

n = 4192

n = 620

 

Female sex

2695 (56.0)

2461 (56.1)

234 (55.1)

ns

Age

 Total (mean, SD)

54.8 (18.0)

55.9 (17.9)

43.6 (15.7)

<0.001

 Men (mean, SD)

54.2 (17.5)

55.4 (17.2)

41.8 (15.4)

 

 Women (mean, SD)

55.4 (18.5)

56.4 (18.4)

45.1 (15.8)

 

Language areab

 German

3778 (78.5)

3473 (79.2)

305 (71.8)

<0.001

 French

687 (14.3)

582 (13.3)

105 (24.7)

 

 Italian

347 (7.2)

332 (7.6)

15 (3.5)

 

Type of residence (urban area)

3799 (78.9)

3446 (78.6)

353 (83.1)

0.03

Health insurance plan

 Managed care

2340 (48.6)

2154 (49.1)

186 (43.8)

0.04

 Higher deductible

522 (10.8)

509 (11.6)

13 (3.1)

<0.001

 Accident coverage

2871 (59.7)

2660 (60.6)

211 (49.7)

<0.001

 Supplementary hospital insurance

1020 (21.2)

948 (21.6)

72 (16.9)

0.03

Home care nursing dependency

285 (5.9)

263 (6.0)

22 (5.2)

<0.001

  1. a p-values, assigning the differences between IBD patients treated with and without biologics, were calculated using fisher’s exact test for dichotomous variables, using Wilcoxon rank sum test for continuous, and using chi-squared test for categorical variables; ns = not significant